Front Row Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-73
| Closed | -$3K | – | 940 |
|
|
2022
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 746 |
|
|
2022
Q3 | $4K | Hold |
73
| – | – | ﹤0.01% | 713 |
|
|
2022
Q2 | $4K | Hold |
73
| – | – | ﹤0.01% | 729 |
|
|
2022
Q1 | $6K | Hold |
73
| – | – | ﹤0.01% | 679 |
|
|
2021
Q4 | $4K | Hold |
73
| – | – | ﹤0.01% | 799 |
|
|
2021
Q3 | $4K | Hold |
73
| – | – | ﹤0.01% | 786 |
|
|
2021
Q2 | $4K | Hold |
73
| – | – | ﹤0.01% | 788 |
|
|
2021
Q1 | $5K | Hold |
73
| – | – | ﹤0.01% | 738 |
|
|
2020
Q4 | $4K | Hold |
73
| – | – | ﹤0.01% | 741 |
|
|
2020
Q3 | $5K | Hold |
73
| – | – | ﹤0.01% | 696 |
|
|
2020
Q2 | $4K | Hold |
73
| – | – | ﹤0.01% | 705 |
|
|
2020
Q1 | $3K | Hold |
73
| – | – | ﹤0.01% | 754 |
|
|
2019
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 733 |
|
|
2019
Q3 | $3K | Hold |
73
| – | – | ﹤0.01% | 736 |
|
|
2019
Q2 | $3K | Hold |
73
| – | – | ﹤0.01% | 759 |
|
|
2019
Q1 | $3K | Hold |
73
| – | – | ﹤0.01% | 758 |
|
|
2018
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 704 |
|
|
2018
Q3 | $3 | Hold |
73
| – | – | ﹤0.01% | 713 |
|
|
2018
Q2 | $3 | Hold |
73
| – | – | ﹤0.01% | 769 |
|
|
2018
Q1 | $2K | Hold |
73
| – | – | ﹤0.01% | 803 |
|
|
2017
Q4 | $3K | Buy |
+73
| New | +$3K | ﹤0.01% | 623 |
|